期刊文献+

真核延伸因子1A2与肿瘤 被引量:2

Recent advances in eukaryotic elongation factor 1 alpha 2 and tumor
原文传递
导出
摘要 正常情况下在翻译延伸阶段发挥作用的真核延伸因子1A2(eEF1A2)仅在脑、心脏以及骨骼肌中表达,但最近的研究却发现eEF1A2在许多肿瘤中呈高表达状态且与肿瘤的发生发展密切相关。随着对其在肿瘤发生发展过程中信号传导机制研究的深入,eEF1A2可能成为肿瘤治疗的一个新靶点。 Eukaryotic elongation factor 1 alpha 2(eEF1A2), which plays a role in the translational elongation process, is normally expressed only in the heart, brain and skeletal musle, but recent studies found it is highly expressed in a variety of tumors and closely related to the oncogenesis and development of tumor. As the signal transduction mechanism is clarified, eEF1A2 is likely to become a novel target for tumor therapy.
作者 张鹏 陶凯雄
出处 《国际肿瘤学杂志》 CAS 2011年第3期176-179,共4页 Journal of International Oncology
关键词 肿瘤 真核延伸因子IA2 Neoplasms eEF13.2 protein
  • 相关文献

参考文献17

  • 1Anand N, Murthy S, Amann G, et al. Protein elongation factor eEFIA2 is a putative oncogene in ovarian cancer. Nat Genet, 2002, 31 ( 3 ) :301-305.
  • 2Pinke DE, Kalloger SE, Francetie T, et al. The prognostic significance of elongation factor eEFI A2 in ovarian cancer. Gynecol Oncol, 2008, 108(3) :561-568.
  • 3Tomlinson VA, Newbery H J, Bergmann JH, et al. Expression of eEFI A2 is associated with clear cell histology in ovarian carcinomas: overcxpression of the gene is not dependent on modifications at the eEFIA2 locus. Br J Cancer,2007,96(10) :1613-1620.
  • 4Sharma S, Tammela J, Wang X, et al. Characterization of a putative ovarian oncogene, elongation factor lalpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin Cancer Res, 2007, 13(19): 5889-5896.
  • 5Tomlinson VA, Newbery HJ, Wray NR, et al. Translation elongation factor eEFIA2 is a potential oncoprotein that is overexpressed in twothirds of breast tumours. BMC Cancer, 2005, 5:113.
  • 6Kulkarni G, Turbin DA, Amiri A, et al. Expression of protein elongation factor eEFI A2 predicts favorable outcome in breast cancer. Breast Cancer Res Treat, 2007, 102( 1 ) :31-41.
  • 7Cao H, Zhu Q, Huang J, et al. Regulation and fanetional role of eEFIA2 in pancreatic carcinoma. Bioehem Biophys Res Commun, 2009, 380(1) :11-16.
  • 8Schlaeger C, Longefich T, Schiller C, et al. Etiology-dependent molecular mechanisms in. human hepatocarcinogenesis. Hepatology, 2008, 47(2) :511-520.
  • 9Grassi G, Scaggiante B, Farra R, et aL The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie, 2007, 89(12) : 1544-1552.
  • 10Zhu H, Lain DC, Han KC, et al. High resolution analysis of genom- ie aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett, 2007, 245(1-2): 303-314.

同被引文献26

  • 1Haverstoek BD. Hypertrophic scars and keloids. Clin PediatrMed Surg, 2001,180( 1) : 147.
  • 2Huang G, Krig S,Kowbel D, et al. ZNF217 suppresses celldeath associated with chemotherapy and telomere dysfunction.Hum Mol Genet, 2005,14(21):3219-3225.
  • 3Collins C, Rommens JM, Kowbel D, et al. Positional cloningof ZNF217and NABC1 : genes amplified at 20ql3. 2 and overex-pressed in breast carcinoma. Proc Natl Acad Sci USA, 1998,95(15):8703-8708.
  • 4Watanabe T, Imotol,KatahiraT,et al. Differentially regula-ted genes as putative targets of amplifications at 20q in ovariancancers. Cancer Res, 2002,93(10) :1114-1122.
  • 5Zuhiro Y, Ueki N,Oda T, et al. Identification and character-ization of human ZNF274 cDNA which encodes a novel Krup-ple type zinc-fingers protein having nucleolar targeting ability.Genomics, 2000,65(1):75-80.
  • 6Odeberg J? Rosok 0,Gudmundsson GH,et al. Cloing andcharacterization of ZNF1 89,a novel human Kruppel-like zincfinger gene localized to chromosome 9q22-q31. Genomics,1998,50(2):213-221.
  • 7Nawrath M,Pavlovic J, Moelling K. Inhibition of humanhematopoietic tumor formation by targeting a repressor Myb-KRAB to DNA. Cancer Gene Ther, 2000?7(6) :963-972.
  • 8Nonet GH, Stampfer MR, Chin K, et al. The ZNF217 geneamplified in breast cancers promotes immortalization of humanmammary epithelial cells. Cancer Res,2001,61(4): 1250-1254.
  • 9Kathju S, SatishL,RabikC,et al. Identification of differenti-ally expressed genes in scarless wound healing utilizing poly-merase chain reaction-suppression subtractive hybridization.Wound Repair Regen, 2006,14(4) :413-420.
  • 10Li P,Maines-Bandieml S,Kuo WL,et al. Multiple roles ofthe candidate oncogene ZNF217 in ovarian epithelial neoplasticprogression. Int J Cancer, 2007,120(9) :1863-1873.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部